TG Therapeutics, Inc. (TGTX)
54.29
+0.67
(+1.25%)
USD |
NASDAQ |
Oct 02, 16:00
54.27
-0.02
(-0.04%)
After-Hours: 20:00
TG Therapeutics Price : 54.29 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 54.17 | 54.98 | 53.14 | 54.29 | 1.650M |
| Oct 01, 2026 | 55.58 | 56.12 | 53.59 | 53.62 | 2.123M |
| Sep 30, 2026 | 56.41 | 56.98 | 55.36 | 55.78 | 1.908M |
| Sep 29, 2026 | 56.04 | 56.68 | 54.79 | 56.19 | 1.608M |
| Sep 28, 2026 | 57.35 | 57.66 | 55.88 | 56.19 | 1.442M |
| Sep 25, 2026 | 57.97 | 58.69 | 56.61 | 57.43 | 1.309M |
| Sep 24, 2026 | 55.95 | 57.55 | 55.09 | 57.52 | 1.138M |
| Sep 23, 2026 | 58.11 | 58.25 | 54.78 | 56.00 | 2.120M |
| Sep 22, 2026 | 57.41 | 58.62 | 56.56 | 58.11 | 2.085M |
| Sep 21, 2026 | 57.23 | 58.92 | 56.00 | 57.16 | 2.143M |
| Sep 18, 2026 | 56.98 | 57.73 | 56.18 | 56.87 | 5.169M |
| Sep 17, 2026 | 57.61 | 57.87 | 56.04 | 56.47 | 1.468M |
| Sep 16, 2026 | 53.12 | 57.60 | 53.10 | 55.85 | 2.350M |
| Sep 15, 2026 | 53.59 | 54.41 | 52.50 | 53.04 | 1.759M |
| Sep 14, 2026 | 53.97 | 54.20 | 53.19 | 54.00 | 1.362M |
| Sep 11, 2026 | 55.71 | 56.26 | 53.47 | 53.89 | 1.369M |
| Sep 10, 2026 | 54.36 | 55.41 | 54.01 | 55.39 | 1.368M |
| Sep 09, 2026 | 55.55 | 57.14 | 54.24 | 54.65 | 1.410M |
| Sep 08, 2026 | 55.34 | 55.92 | 54.09 | 55.74 | 1.086M |
| Sep 04, 2026 | 56.30 | 56.70 | 55.56 | 55.98 | 992966.0 |
| Sep 03, 2026 | 57.40 | 58.47 | 56.19 | 56.71 | 1.571M |
| Sep 02, 2026 | 56.18 | 57.87 | 54.70 | 56.90 | 2.362M |
| Sep 01, 2026 | 53.00 | 56.27 | 52.11 | 56.09 | 3.198M |
| Aug 31, 2026 | 53.58 | 54.36 | 52.67 | 54.30 | 1.622M |
| Aug 28, 2026 | 55.53 | 55.53 | 53.83 | 53.93 | 1.031M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Krystal Biotech, Inc. | 322.28 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| BioMarin Pharmaceutical, Inc. | 57.18 |
| Cytokinetics, Inc. | 65.60 |
| Exelixis, Inc. | 58.39 |
Price Related Metrics
| PE Ratio | 19.77 |
| PS Ratio | 10.83 |
| PEG Ratio | 0.0312 |
| Price to Book Value | 13.76 |
| Price to Free Cash Flow | 497.86 |
| Earnings Yield | 5.06% |
| Market Cap | 8.311B |
| PEGY Ratio | 0.0312 |
| Operating PE Ratio | 63.49 |
| Normalized PE Ratio | 19.40 |